Get started
BADQOMOCAWGOWLD

$ATXI entry 1.35-1.45 Target PT 5-7-11 and higher

Long
Avenue Therapeutics, Inc. (NASDAQ:ATXI)  
BADQOMOCAWGOWLD  
NASDAQ:ATXI   Avenue Therapeutics, Inc.
Beyond Technical Analysis Wave Analysis Technical Indicators Divergence Bullish Patterns signal signals strength target
2
0
beyondta waveanalysis indicator divergence bullish signal signals strength target
Avenue Therapeutics, Inc., a specialty pharmaceutical company, acquires, licenses, develops, and commercializes products primarily for use in the acute/intensive care hospital setting. Its product candidate is intravenous Tramadol, which is in Phase III clinical trials to treat moderate to moderately severe post-operative pain. The company was incorporated in 2015 and is based in New York, New York.
Disclaimer

The information and publications are not meant to be, and do not constitute, financial, investment, trading, or other types of advice or recommendations supplied or endorsed by TradingView. Read more in the Terms of Use.